Alternatives to Rivas Medical Weight Loss

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

The habit-plus-medication route: Noom bolts a prescriber onto its behavior-change app, runs mostly async, and will chase brand-name coverage through insurance — but it won't tell you which molecule you're getting or your true quarterly total up front.

The number on the page is a prepay. Read live on 2026-08-26, GOAL.MD's semaglutide page leads with $99 a month and its tirzepatide page with $159 — and both are 12-month prepaid equivalents, $1,188 and $1,908 handed over up front. Month to month, the same two medications are $179 and $249. The site does say so, in the same sentence, but second. Everything around that pricing is unusually clean for this roster: a named physician with a searchable NPI rather than an anonymous clinical network, "No Auto-Billing. Ever." with a stated check-in before every renewal, a 3-minute online medical visit with no video call mentioned anywhere in the copy, and a published timeline — physician decision in about 24 hours, free shipping in 2–3 days. Two corrections to make if you are comparing: it serves 48 states rather than the whole country, and its brand-name lane is a forwarding service where you pay GOAL.MD $95 a month for supervision and the manufacturer program directly for the drug.

No scheduled video visit, but no published turnaround time either — a $49/mo membership plus medication billed separately lands around $348/mo all-in for either molecule.

$249 semaglutide, $349 tirzepatide, month to month, flat at every dose. Those are the only recurring rates. The cheaper tiers are prepayment — '$159/mo' is $477 once, three months shipped together, select states only. Brand Wegovy and Zepbound available as a $99 care fee, drug billed separately. FDA letter 717991 from February 2026, still open; the cited claims have been removed from the site.

FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, and licensed in all 50 states. It also cites customer-reported outcomes (125k patients, 1M+ pounds lost) rather than leaving weight-loss claims unsourced.

A broader wellness platform (GLP-1s plus NAD+, sermorelin, HRT, hair growth) offering both compounded ($199/mo semaglutide, $299/mo tirzepatide) and brand-name Ozempic/Zepbound access — though the site shows three different, unreconciled price claims across its own pages, so confirm the real number at signup. The three are the $199/mo standing tier, a $169/mo three-month prepay plan badged 'Best Value', and a countdown-timer banner advertising 'as low as $119/mo' that matches neither. Brand-name access is listed only as 'also available', with no price shown on any page we checked, so the compounded tiers are the only figures you can plan around.

The widest menu on the board — compounded, oral and four brand pens, all on a chat visit with no camera — sold behind a pricing page that quotes you a monthly figure for a plan you have to pay for a year in advance.

A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo.